Gottlieb: FDA unprepared for follow-on biologics

Share this article:
Former FDA deputy commissioner for medical and scientific affairs Scott Gottlieb, now a senior fellow at the American Enterprise Institute, has expressed serious concern that his former agency may be unprepared to conduct regulatory reviews of generic or follow-on biologics, when and if Congress passes legislation establishing a regulatory pathway for such products.

Speaking in November before a Food & Drug Law Institute-sponsored conference on generic biologics, Gottlieb said he did not believe the FDA has “thought through” who, and which organizational elements, should assume responsibility for regulatory reviews for biosimilars. Unless this issue is carefully considered, he predicted there could be significant delays in approvals.

Gottlieb said his concern is based on impressions, gained during his tenure with the agency, on what he now views as the cause for many delays in approvals. “Many people believe that delays in generic drug approvals can be attributed mainly to citizen petitions, or delaying tactics engaged in by innovator companies,” he said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.